The company is moving out of the…
The company is moving out of the building that used [...]
Biogen has agreed to a settlement…
Biogen has agreed to a settlement with investors who claimed [...]
With a solid year of double-digit…
With a solid year of double-digit revenue growth in the [...]
Johnson & Johnson’s…
Johnson & Johnson’s immunology drug Tremfya is looking to challenge [...]
The plummeting demand for…
The plummeting demand for Merck’s HPV vaccine Gardasil in China [...]
Halozyme is putting a recent…
Halozyme is putting a recent drug-delivery acquisition to work thanks [...]
The FDA is seeking new powers to…
The FDA is seeking new powers to hold companies accountable [...]
In response to a warning letter…
In response to a warning letter from the FDA that [...]
A recent episode of ABC’s Scrubs…
A recent episode of ABC’s Scrubs featured an on-screen brand [...]
Neurocrine Biosciences, forever a…
Neurocrine Biosciences, forever a possible M&A target in the biopharma [...]